STAA
STAAR Surgical Company
NASDAQ: STAA · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$26.78
+0.34% today
Updated 2026-11-12
Market cap
$1.34B
P/E ratio
2,669.00
P/S ratio
4.08x
EPS (TTM)
$0.01
Dividend yield
—
52W range
$16 – $36
Volume
0.9M
STAAR Surgical Company (STAA) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$26.78
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$34.47
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.2B | $0.3B | $0.3B | $0.3B | $0.2B | $0.3B | $0.3B | $0.3B | $0.3B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 7.93% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 0.16%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.